Duloxetine vs Nivolumab

Duloxetine vs Nivolumab: Overview

This comparison examines the pharmacological differences between Duloxetine and Nivolumab.

Mechanism of Action

Duloxetine: Serotonin-norepinephrine reuptake inhibitor (SNRI).

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Duloxetine — 12 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Duloxetine — C18H19NOS.

Molecular Weight: Duloxetine — 297.4150 g/mol.

Type: Duloxetine — Small molecule; Nivolumab — Antibody.